Your browser doesn't support javascript.
loading
Corrigendum: STAT5a Confers Doxorubicin Resistance to Breast Cancer by Regulating ABCB1.
Li, Zhaoqing; Chen, Cong; Chen, Lini; Hu, Dengdi; Yang, Xiqian; Zhuo, Wenying; Chen, Yongxia; Yang, Jingjing; Zhou, Yulu; Mao, Misha; Zhang, Xun; Xu, Ling; Ju, Siwei; Shen, Jun; Wang, Qinchuan; Dong, Minjun; Xie, Shuduo; Wei, Qun; Jia, Yunlu; Zhou, Jichun; Wang, Linbo.
Affiliation
  • Li Z; Cancer Institute (Key Laboratory of Cancer Prevention and Intervention, China National Ministry of Education), 2nd Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China.
  • Chen C; Sir Run Run Shaw Hospital, Zhejiang University, Hangzhou, China.
  • Chen L; Biomedical Research Center and Key Laboratory of Biotherapy of Zhejiang Province, Hangzhou, China.
  • Hu D; Sir Run Run Shaw Hospital, Zhejiang University, Hangzhou, China.
  • Yang X; Biomedical Research Center and Key Laboratory of Biotherapy of Zhejiang Province, Hangzhou, China.
  • Zhuo W; Sir Run Run Shaw Hospital, Zhejiang University, Hangzhou, China.
  • Chen Y; Biomedical Research Center and Key Laboratory of Biotherapy of Zhejiang Province, Hangzhou, China.
  • Yang J; Sir Run Run Shaw Hospital, Zhejiang University, Hangzhou, China.
  • Zhou Y; Biomedical Research Center and Key Laboratory of Biotherapy of Zhejiang Province, Hangzhou, China.
  • Mao M; Affiliated Cixi Hospital, Wenzhou Medical University, Ningbo, China.
  • Zhang X; Sir Run Run Shaw Hospital, Zhejiang University, Hangzhou, China.
  • Xu L; Biomedical Research Center and Key Laboratory of Biotherapy of Zhejiang Province, Hangzhou, China.
  • Ju S; Breast Surgical Department, Shaoxing Maternity and Child Health Care Hospital, Shaoxing, China.
  • Shen J; Sir Run Run Shaw Hospital, Zhejiang University, Hangzhou, China.
  • Wang Q; Biomedical Research Center and Key Laboratory of Biotherapy of Zhejiang Province, Hangzhou, China.
  • Dong M; Affiliated Cixi Hospital, Wenzhou Medical University, Ningbo, China.
  • Xie S; Sir Run Run Shaw Hospital, Zhejiang University, Hangzhou, China.
  • Wei Q; Biomedical Research Center and Key Laboratory of Biotherapy of Zhejiang Province, Hangzhou, China.
  • Jia Y; Sir Run Run Shaw Hospital, Zhejiang University, Hangzhou, China.
  • Zhou J; Biomedical Research Center and Key Laboratory of Biotherapy of Zhejiang Province, Hangzhou, China.
  • Wang L; Sir Run Run Shaw Hospital, Zhejiang University, Hangzhou, China.
Front Oncol ; 12: 880458, 2022.
Article de En | MEDLINE | ID: mdl-35356217
[This corrects the article DOI: 10.3389/fonc.2021.697950.].
Mots clés
Texte intégral
Ajouter à My VHL
Imprimer
XML
PubMed Links
Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Langue: En Journal: Front Oncol Année: 2022 Type de document: Article Pays d'affiliation: Chine Pays de publication: Suisse
Texte intégral
Ajouter à My VHL
Imprimer
XML
PubMed Links
Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Langue: En Journal: Front Oncol Année: 2022 Type de document: Article Pays d'affiliation: Chine Pays de publication: Suisse